Journal of the American College of Cardiology: Volume 79 (Issue 1 to Issue 25)
It seems like you’re describing the Journal of the American College of Cardiology (JACC), a highly reputable medical journal focused on cardiovascular research. It serves as an essential platform for researchers, clinicians, and academics in the field, offering them the opportunity to publish their findings on a broad range of topics in cardiovascular disease. Your description covers its scope quite comprehensively, from original clinical and experimental studies to abstracts from the annual American College of Cardiology conferences.
The journal’s multidisciplinary approach enables a 360-degree view of cardiovascular health, including innovative techniques for diagnosis, treatment plans, pharmacology, and surgical interventions. It is especially crucial in a field that is rapidly evolving, with emerging technologies and treatment protocols continuously improving patient care.
By offering a balanced mix of clinical and experimental studies, JACC helps bridge the gap between laboratory findings and practical, real-world applications. Moreover, its focus on large multicenter trials offers the medical community valuable insights into the efficacy and safety of new therapies, guiding future research and influencing clinical guidelines.
The inclusion of reports from the Bethesda Conferences is another key feature, as these conferences often set the stage for current and future directions in cardiovascular research and treatment.
Overall, JACC plays a pivotal role in shaping the field of cardiovascular medicine by providing high-quality, peer-reviewed content that aids clinicians in making evidence-based decisions, thereby improving patient outcomes.
Did you have a specific question about JACC or cardiovascular research that you’d like to know more about?
Volume 79, Issue 1: Pages A1-A32, e1-e14, 1-100 (4–11 January 2022)
Volume 79, Issue 2: Pages e15-e133, 101-222 (18 January 2022)
Volume 79, Issue 3: Pages A1-A40, e135-e144, 223-310 (25 January 2022)
Volume 79, Issue 4: Pages A1-A30, e145-e153, 311-416 (1 February 2022)
Volume 79, Issue 5: Pages A1-A32, e155-e161, 417-512 (8 February 2022)
Volume 79, Issue 6: Pages e163-e168, 513-616 (15 February 2022)
Volume 79, Issue 7: Pages e169-e177, 617-756 (22 February 2022)
Volume 79, Issue 8: Pages e179-e187, A1-A36, 757-848 (1 March 2022)
Volume 79, Issue 9, Supplement: Pages 1-3489 (8 March 2022)
Volume 79, Issue 9: Pages e189-e198, A1-A26, 849-950 (8 March 2022)
Volume 79, Issue 10: Pages e199-e207, 951-1034 (15 March 2022)
Volume 79, Issue 11: Pages e209-e213, 1035-1128, A1-A26 (22 March 2022)
Volume 79, Issue 12: Pages 1129-1222, A1-A34, e215-e224 (29 March 2022)
Volume 79, Issue 13: Pages e225-e233, 1223-1319, A1-A30 (5 April 2022)
Volume 79, Issue 14: Pages A1-A40, e235-e243, 1321-1428 (12 April 2022)
27th Cardiovascular Summit TCTAP 2022
27th Cardiovascular Summit Transcatheter Cardiovascular Therapeutics Asia Pacific (TCTAP)
(TCTAP 2022)
27-29 April 2022 • Virtual • TCTAP is sponsored by the CardioVascular Research Foundation (CVRF).
Volume 79, Issue 15, Supplement, Pages S1-S416 (19 April 2022)
Reviews
There are no reviews yet.